Zhao W - Search Results

1

Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.

Wang J, Wang B, Zhao W, Guo Y, Chen H, Chu H, Liang X, Bi J. Wang J, et al. Among authors: zhao w. PLoS One. 2012;7(12):e52704. doi: 10.1371/journal.pone.0052704. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23285161 Free PMC article.

2

The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.

Wang J, Zhao W, Guo Y, Zhang B, Xie Q, Xiang D, Gao J, Wang B, Chen Z. Wang J, et al. Among authors: zhao w. Oncology. 2009;76(6):420-9. doi: 10.1159/000216837. Epub 2009 May 5. Oncology. 2009. PMID: 19420963

3

IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.

Zhao W, Wang J, Zhu B, Duan Y, Chen F, Nian W, Sun J, Zhang B, Tong Z, Chen Z. Zhao W, et al. Oncol Rep. 2016 Mar;35(3):1483-92. doi: 10.3892/or.2015.4516. Epub 2015 Dec 24. Oncol Rep. 2016. PMID: 26706909

4

Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.

Zhao W, Li X, Wang J, Wang C, Jia Y, Yuan S, Huang Y, Shi Y, Tong Z. Zhao W, et al. Med Sci Monit. 2017 Aug 30;23:4182-4191. doi: 10.12659/msm.906389. Med Sci Monit. 2017. PMID: 28854163 Free PMC article.

5

SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer.

Zhao W, Sun L, Li X, Wang J, Zhu Y, Jia Y, Tong Z. Zhao W, et al. Sci Rep. 2021 Apr 26;11(1):8976. doi: 10.1038/s41598-021-88258-9. Sci Rep. 2021. PMID: 33903614 Free PMC article.

6

Excellent Response to Atezolizumab After Clinically Defined Hyperprogression Upon Previous Treatment With Pembrolizumab in Metastatic Triple-Negative Breast Cancer: A Case Report and Review of the Literature.

Feng D, Guan Y, Liu M, He S, Zhao W, Yin B, Liang J, Li Y, Wang J. Feng D, et al. Among authors: zhao w. Front Immunol. 2021 May 31;12:608292. doi: 10.3389/fimmu.2021.608292. eCollection 2021. Front Immunol. 2021. PMID: 34135884 Free PMC article. Review.

7

Ribosome Proteins Represented by RPL27A Mark the Development and Metastasis of Triple-Negative Breast Cancer in Mouse and Human.

Zhao W, Li X, Nian W, Wang J, Wang X, Sun L, Zhu Y, Tong Z. Zhao W, et al. Front Cell Dev Biol. 2021 Aug 23;9:716730. doi: 10.3389/fcell.2021.716730. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34497807 Free PMC article.

8

Neutralization of complement regulatory proteins CD55 and CD59 augments therapeutic effect of herceptin against lung carcinoma cells.

Zhao WP, Zhu B, Duan YZ, Chen ZT. Zhao WP, et al. Oncol Rep. 2009 Jun;21(6):1405-11. doi: 10.3892/or_00000368. Oncol Rep. 2009. PMID: 19424617

9

[Experimental study of SHP-1 promoter methylation in myelodysplastic syndromes and its related mechanism].

Zhang YZ, Zhao DD, Zhao WP, Zhao HF, Zhao ZG, Wang YF, Wu XX, Han XP, Da WM. Zhang YZ, et al. Zhonghua Xue Ye Xue Za Zhi. 2012 Feb;33(2):108-12. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22730659 Chinese.

10

Expression of CXCR4 is an independent prognostic factor for overall survival and progression-free survival in patients with myelodysplastic syndrome.

Zhang Y, Guo Q, Zhao H, Zhao D, Wu X, Zhao W, Wang Y, Xia B, Da W. Zhang Y, et al. Among authors: zhao h, zhao w, zhao d. Med Oncol. 2013 Mar;30(1):341. doi: 10.1007/s12032-012-0341-6. Epub 2012 Dec 22. Med Oncol. 2013. PMID: 23263827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,221 results

Search Page

Filters